Multimodal Ayurvedic intervention provided 15 years of progression free survival to a female patient with recurrent squamous cell carcinoma of tongue - A case report

No Thumbnail Available
Date
2025-06
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier B.V.
Abstract
Oral Squamous Cell Carcinoma (OSCC) is the most common type of oral cancer, accounting for 90%–95% of all cancers in the mouth. It is typically noted in individuals over the age of 40, especially men between 60 and 80. However, there has been a recent increase in oral cancer cases among women and younger individuals. We present a case of a 49-year-old female diagnosed with Stage III, moderately differentiated Squamous cell carcinoma of the tongue in August 2005. The patient underwent radiation therapy (35 fractions/70 Gy) and received adjunct chemotherapy (6 cycles of Inj. Cisplatin – LD on October 21, 2005). Despite these treatments, residual induration on the tongue persisted, leading to a Knife biopsy in April 2007 that confirmed the presence of squamous carcinoma infiltrating the lingual muscles. Further, she underwent Wide Excision Glossectomy with Left Supra-Omohyoid Neck Dissection in May 2007 and Total Glossectomy with Hemi mandibulectomy with Left Supra-Omohyoid Neck Dissection in August 2011. In addition to conventional cancer treatments, the patient opted for Ayurvedic treatment at our center, which included a combination of oral Herbo-mineral metallic medicines and detoxifying Panchakarma procedures. The 12-year progression-free survival achieved in this case highlights the potential benefits of combining conventional cancer treatment with personalized adjunct Ayurvedic therapy.
Description
Keywords
Ayurveda, Oral squamous cell carcinoma, Panchakarma, Rasayana, Tongue cancer
Citation
S S, D V, G V, D S, K S, D S, B S, G S, C S. Multimodal Ayurvedic intervention provided 15 years of progression free survival to a female patient with recurrent squamous cell carcinoma of tongue - A case report. Journal of Ayurveda and Integrative Medicine. 2025 Jun; 16(3): 1-10